In 2023, Germany dominated the European market for medicaments containing vitamins and derivatives, holding a significant share with minimal growth. Italy and Spain showed strong double-digit growth over the year, underscoring their expanding role. Meanwhile, France faced a decline, and Denmark experienced a substantial reduction in production share. Poland and other Eastern European countries maintained stable or slightly negative growth, with minor shifts affecting their market positions. Over the past five years, the sector has seen moderate Compound Annual Growth Rate (CAGR), indicating gradual expansion in this market segment.
Future trends in the European medicaments market include potential shifts due to increased health awareness and demand for vitamin-enriched products. Watch for enhanced regulatory frameworks and innovation-driven competition, fostering diverse product offerings. Additionally, trade policies and economic conditions may influence production dynamics, especially in smaller markets experiencing volatility.
Top countries in Sold Production of Medicaments Containing Vitamins, Provitamins, Derivatives and Intermixtures Thereof Share by Country (Euros)
| # | 10 Countries | Percent | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 Germany | 65.44 | 2023 | +3.19% | +1.74% | View data |
| 2 | 2 Italy | 8.48 | 2023 | +10.21% | +14.63% | View data |
| 3 | 3 United Kingdom | 6.38 | 2023 | +1.87% | +2.41% | View data |
| 4 | 4 Spain | 5.43 | 2023 | +11.18% | +12.25% | View data |
| 5 | 5 Ireland | 4.46 | 2021 | +20.79% | View data | |
| 6 | 6 Austria | 3.09 | 2023 | +5.68% | +9.8% | View data |
| 7 | 7 France | 1.83 | 2023 | -8.87% | -6.8% | View data |
| 8 | 8 Hungary | 1.52 | 2023 | +3.49% | +4.29% | View data |
| 9 | 9 Greece | 0.99 | 2023 | +2.28% | +3.06% | View data |
| 10 | 10 Poland | 0.97 | 2023 | +0.58% | -0.85% | View data |
